GoKawiilMIT Technology Review to host live discussion on AI extinction risk; researcher's eye age-reversal therapy enters human trials
MIT Technology Review is holding a subscriber-only roundtable on September 15 with editors and an AI reporter to examine claims that artificial intelligence poses an extinction-level threat to humanity. Separately, the outlet profiles geneticist Yuancheng (Ryan) Lu, whose cellular reprogramming technique reversed blindness in mice by repairing optic nerves, and reports that a similar gene therapy has now moved into human clinical trials. Lu was also named to the publication's 2026 list of top young innovators in biotechnology and health.